JP Stock MarketDetailed Quotes

4528 Ono Pharmaceutical

Watchlist
  • 2181.5
  • -38.0-1.71%
20min DelayMarket Closed Jul 5 15:00 JST
1.02TMarket Cap8.18P/E (Static)

Ono Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
12.41%502.67B
4.25%112.77B
7.25%131.19B
26.11%138.7B
12.46%120.02B
23.75%447.19B
20.28%108.17B
25.64%122.32B
26.83%109.98B
22.16%106.72B
Cost of revenue
15.50%127.13B
20.51%31.66B
2.07%30.7B
29.20%34.59B
12.01%30.17B
17.70%110.06B
14.85%26.28B
19.98%30.08B
17.60%26.78B
18.15%26.94B
Gross profit
11.40%375.55B
-0.96%81.11B
8.94%100.49B
25.12%104.1B
12.61%89.84B
25.86%337.12B
22.13%81.89B
27.61%92.24B
30.12%83.21B
23.58%79.79B
Operating expense
10.48%215.61B
5.24%65.8B
5.96%52.9B
17.81%48.42B
16.51%48.5B
18.53%195.16B
35.83%62.52B
3.39%49.93B
15.55%41.1B
19.70%41.62B
Selling and administrative expenses
12.05%100.27B
15.58%26.98B
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
13.46%21.22B
14.62%21.73B
-General and administrative expense
12.05%100.27B
15.58%26.98B
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
13.46%21.22B
14.62%21.73B
Research and development costs
17.65%112.17B
21.49%35.68B
2.98%27.13B
22.58%24.78B
26.61%24.58B
25.65%95.34B
11.19%29.37B
55.78%26.35B
16.81%20.22B
27.34%19.41B
Other operating expenses
-60.75%4.34B
-66.72%3.34B
-62.33%165M
2,308.33%289M
-6.27%553M
-12.86%11.07B
3,531.88%10.02B
-96.23%438M
-70.00%12M
-22.37%590M
Total other operating income
60.22%1.18B
-8.80%197M
39.34%85M
121.08%776M
11.32%118M
-25.10%734M
-8.09%216M
-19.74%61M
-27.03%351M
-43.62%106M
Operating profit
12.66%159.94B
-20.97%15.31B
12.46%47.59B
32.25%55.69B
8.35%41.35B
37.57%141.96B
-7.87%19.37B
76.37%42.32B
48.38%42.11B
28.09%38.16B
Net non-operating interest income (expenses)
142.68%3.8B
616.36%1.14B
-60.96%406M
1,013.43%1.22B
17.27%1.03B
-14.76%1.57B
36.78%-220M
-7.39%1.04B
-385.11%-134M
-13.13%880M
Non-operating interest income
62.51%4.03B
1,214.49%907M
27.59%1.51B
1,813.85%1.24B
9.84%1.27B
-8.56%2.48B
-60.12%69M
5.52%1.19B
-38.10%65M
-11.93%1.16B
Non-operating interest expense
-74.92%229M
-179.24%-229M
662.76%1.11B
-89.95%20M
-13.62%241M
4.46%913M
-44.53%289M
--145M
243.10%199M
-7.92%279M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
-75.00%1M
-3M
0
100.00%6M
-2M
166.67%4M
0
1M
3M
0
Special income (charges)
Other non-operating income (expenses)
Income before tax
14.07%163.73B
-14.15%16.44B
10.69%48B
35.59%56.92B
8.55%42.38B
36.66%143.53B
-7.37%19.15B
72.63%43.36B
47.67%41.98B
26.74%39.04B
Income tax
16.57%35.69B
-147.78%-988M
19.36%11.91B
56.84%14.22B
11.01%10.56B
25.80%30.62B
-55.62%2.07B
47.06%9.98B
46.19%9.06B
42.05%9.51B
Net income
13.40%128.04B
2.01%17.43B
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.69%17.09B
82.08%33.39B
48.09%32.91B
22.48%29.53B
Net income continuous operations
13.40%128.04B
2.02%17.43B
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.67%17.09B
82.08%33.39B
48.09%32.91B
22.49%29.53B
Noncontrolling interests
-67.37%62M
-122.22%-4M
-45.59%37M
-44.23%29M
0
14.46%190M
-84.75%18M
1,260.00%68M
420.00%52M
50.00%51M
Net income attributable to the company
13.53%127.98B
2.14%17.43B
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
47.92%32.86B
22.44%29.48B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
13.53%127.98B
2.14%17.43B
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
47.92%32.86B
22.44%29.48B
Gross dividend payment
Basic earnings per share
15.49%266.61
7.38%37.53
11.05%75.77
31.03%88.18
7.93%65.16
42.33%230.85
7.27%34.95
85.26%68.23
51.20%67.3
25.17%60.37
Diluted earnings per share
15.50%266.57
7.45%37.51
11.05%75.76
31.03%88.18
7.94%65.15
42.32%230.79
7.18%34.91
85.28%68.22
51.24%67.3
25.18%60.36
Dividend per share
14.29%80
8.11%40
0
21.21%40
0
25.00%70
32.14%37
0
17.86%33
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue 12.41%502.67B4.25%112.77B7.25%131.19B26.11%138.7B12.46%120.02B23.75%447.19B20.28%108.17B25.64%122.32B26.83%109.98B22.16%106.72B
Cost of revenue 15.50%127.13B20.51%31.66B2.07%30.7B29.20%34.59B12.01%30.17B17.70%110.06B14.85%26.28B19.98%30.08B17.60%26.78B18.15%26.94B
Gross profit 11.40%375.55B-0.96%81.11B8.94%100.49B25.12%104.1B12.61%89.84B25.86%337.12B22.13%81.89B27.61%92.24B30.12%83.21B23.58%79.79B
Operating expense 10.48%215.61B5.24%65.8B5.96%52.9B17.81%48.42B16.51%48.5B18.53%195.16B35.83%62.52B3.39%49.93B15.55%41.1B19.70%41.62B
Selling and administrative expenses 12.05%100.27B15.58%26.98B10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B13.46%21.22B14.62%21.73B
-General and administrative expense 12.05%100.27B15.58%26.98B10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B13.46%21.22B14.62%21.73B
Research and development costs 17.65%112.17B21.49%35.68B2.98%27.13B22.58%24.78B26.61%24.58B25.65%95.34B11.19%29.37B55.78%26.35B16.81%20.22B27.34%19.41B
Other operating expenses -60.75%4.34B-66.72%3.34B-62.33%165M2,308.33%289M-6.27%553M-12.86%11.07B3,531.88%10.02B-96.23%438M-70.00%12M-22.37%590M
Total other operating income 60.22%1.18B-8.80%197M39.34%85M121.08%776M11.32%118M-25.10%734M-8.09%216M-19.74%61M-27.03%351M-43.62%106M
Operating profit 12.66%159.94B-20.97%15.31B12.46%47.59B32.25%55.69B8.35%41.35B37.57%141.96B-7.87%19.37B76.37%42.32B48.38%42.11B28.09%38.16B
Net non-operating interest income (expenses) 142.68%3.8B616.36%1.14B-60.96%406M1,013.43%1.22B17.27%1.03B-14.76%1.57B36.78%-220M-7.39%1.04B-385.11%-134M-13.13%880M
Non-operating interest income 62.51%4.03B1,214.49%907M27.59%1.51B1,813.85%1.24B9.84%1.27B-8.56%2.48B-60.12%69M5.52%1.19B-38.10%65M-11.93%1.16B
Non-operating interest expense -74.92%229M-179.24%-229M662.76%1.11B-89.95%20M-13.62%241M4.46%913M-44.53%289M--145M243.10%199M-7.92%279M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests -75.00%1M-3M0100.00%6M-2M166.67%4M01M3M0
Special income (charges)
Other non-operating income (expenses)
Income before tax 14.07%163.73B-14.15%16.44B10.69%48B35.59%56.92B8.55%42.38B36.66%143.53B-7.37%19.15B72.63%43.36B47.67%41.98B26.74%39.04B
Income tax 16.57%35.69B-147.78%-988M19.36%11.91B56.84%14.22B11.01%10.56B25.80%30.62B-55.62%2.07B47.06%9.98B46.19%9.06B42.05%9.51B
Net income 13.40%128.04B2.01%17.43B8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.69%17.09B82.08%33.39B48.09%32.91B22.48%29.53B
Net income continuous operations 13.40%128.04B2.02%17.43B8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.67%17.09B82.08%33.39B48.09%32.91B22.49%29.53B
Noncontrolling interests -67.37%62M-122.22%-4M-45.59%37M-44.23%29M014.46%190M-84.75%18M1,260.00%68M420.00%52M50.00%51M
Net income attributable to the company 13.53%127.98B2.14%17.43B8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B47.92%32.86B22.44%29.48B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 13.53%127.98B2.14%17.43B8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B47.92%32.86B22.44%29.48B
Gross dividend payment
Basic earnings per share 15.49%266.617.38%37.5311.05%75.7731.03%88.187.93%65.1642.33%230.857.27%34.9585.26%68.2351.20%67.325.17%60.37
Diluted earnings per share 15.50%266.577.45%37.5111.05%75.7631.03%88.187.94%65.1542.32%230.797.18%34.9185.28%68.2251.24%67.325.18%60.36
Dividend per share 14.29%808.11%40021.21%40025.00%7032.14%37017.86%330
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg